for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Daxor Corporation

DXR

Latest Trade

15.12USD

Change

-0.24(-1.56%)

Volume

2,814

Today's Range

15.10

 - 

16.14

52 Week Range

7.85

 - 

24.08

As of on the NYSE MKT LLC ∙ Minimum 15 minute delay

Pricing

Previous Close
15.36
Open
15.61
Volume
2,814
3M AVG Volume
0.23
Today's High
16.14
Today's Low
15.10
52 Week High
24.08
52 Week Low
7.85
Shares Out (MIL)
3.89
Market Cap (MIL)
58.80
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Daxor Corp Buys BVA-100 Blood Volume Analyzer To Aspirus Wausau Hospital In Wisconsin

Daxor Corp Initiates Strategic Collaboration With CHF Solutions Inc

Daxor Corporation Appoints Robert Michel As CFO

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Daxor Corporation

Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The Company focuses on the development of the Blood Volume Analyzer (BVA) -100, an instrument that rapidly and accurately measures human blood volume. The Company’s instrument is used in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.The Company also owns the Daxor Oak Ridge Operations (DORO) facility in Oak Ridge, Tennessee. The semi-automated BVA provides blood volume measurements in human body for diagnosis and treatment in a range of medical and surgical conditions.

Industry

Medical Equipment & Supplies

Contact Info

350 5th Ave Ste 4740

NEW YORK, NY

10118-0002

United States

+1.212.3308500

http://www.daxor.com/

Executive Leadership

Michael Richard Feldschuh

Chairman of the Board, President, Chief Executive Officer

Robert J. Michel

Chief Financial Officer

Jonathan Adam Feldschuh

Chief Scientific Officer, Director

Henry Cremisi

Director

Edward Feuer

Director

Key Stats

2.00 mean rating - 2 analysts
Sell
Hold
Buy
Price To Earnings (TTM)
--
Price To Sales (TTM)
192.04
Price To Book (MRQ)
5.27
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
8.11
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-36.19
Return on Equity (TTM)
-27.14

Latest News

Latest News

BRIEF-Daxor Announces New Distribution Agreement With American Medical Depot Government Distributor

* DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH AMERICAN MEDICAL DEPOT GOVERNMENT DISTRIBUTOR Source text for Eikon: Further company coverage:

BRIEF-Daxor Corp Announced First Use Of Its BVA-100 Test To Guide Volume Treatment In A Patient Infected With COVID-19 Virus

* DAXOR CORP - ANNOUNCED FIRST USE OF ITS BVA-100 TEST TO GUIDE VOLUME TREATMENT IN A PATIENT INFECTED WITH COVID-19 VIRUS Source text for Eikon: Further company coverage:

BRIEF-Daxor Corporation Announces Pricing Of $2 Mln Registered Direct Offering Priced At-The-Market

* DAXOR CORPORATION ANNOUNCES PRICING OF $2.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET

BRIEF-Daxor Corp Announces Engagement With Hospitals And Government For Use Of The Blood Volume Analyzer To Stem COVID-19 Deaths

* DAXOR CORPORATION ANNOUNCES ENGAGEMENT WITH HOSPITALS AND GOVERNMENT FOR USE OF THE BLOOD VOLUME ANALYZER (BVA-100®) TO STEM COVID-19 DEATHS Source text for Eikon: Further company coverage:

BRIEF-Daxor Corporation Announces Rise In Kit Sales And Files Form N-CSR For 2019

* DAXOR CORPORATION ANNOUNCES RISE IN KIT SALES AND FILES FORM N-CSR FOR 2019 Source text for Eikon: Further company coverage:

BRIEF-Daxor Corp Files For Stock Shelf Of Upto $28 Million

* DAXOR CORP FILES FOR STOCK SHELF OF UPTO $28 MILLION - SEC FILING Source text: (https://bit.ly/2HFzeaN) Further company coverage:

BRIEF-Daxor Corporation Revises 2017 Dividend

* DAXOR CORP - BOARD OF DIRECTORS HAS REAFFIRMED ANNUAL DIVIDEND PAYMENT OF $0.03 PER SHARE

BRIEF-Daxor Corporation announces share buyback program

* Daxor Corp - re-authorize company's share buyback for an amount of up to 300,000 shares for next 12 months. Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up